GlobeNewswire
Beyond Air® Announces Transition of Chief Financial Officer
📊
AI Sentiment
Positive
6/10
- Home
- XAIR
XAIR
Beyond Air Inc.
as of 11-28-2025 10:50am EST
$1.35
+$0.02
+1.54%
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
Chart Type:
Time Range:
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | GARDEN CITY |
| Market Cap: | 10.5M | IPO Year: | N/A |
| Target Price: | $11.00 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.24 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.19 - $11.56 | Next Earning Date: | 11-10-2025 |
| Revenue: | $5,802,000 | Revenue Growth: | 147.74% |
| Revenue Growth (this year): | 261.11% | Revenue Growth (next year): | 151.82% |
AI-Powered XAIR Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 73.43%
73.43%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Beyond Air Inc. News
XAIR Breaking Stock News: Dive into XAIR Ticker-Specific Updates for Smart Investing
Compare XAIR vs Leading Stocks
See how XAIR stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "XAIR Beyond Air Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.